Anterogen Co Ltd
KOSDAQ:065660
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Anterogen Co Ltd
KOSDAQ:065660
|
KR |
|
B
|
Bridgestone Corp
XMUN:BGT
|
JP |
|
W
|
Wallbridge Mining Company Ltd
XMUN:WC7
|
CA |
|
H
|
Huntington Bancshares Inc
XMUN:HU3
|
US |
Intrinsic Value
Is Anterogen Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Anterogen Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Anterogen Co Ltd looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with Anterogen Co Ltd’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Anterogen Does
Anterogen is a South Korean regenerative medicine company that develops and sells cell-based therapies, especially stem cell treatments made from human tissue. Its best-known products are used in hospitals for difficult conditions such as inflammatory and tissue-repair diseases, where standard drugs may not be enough.
- Headquarters
- Korea KR
- Employees
- 43
- IPO date
- Feb 15, 2016
Revenue & Expenses Breakdown
Anterogen Co Ltd
Earnings Waterfall
Anterogen Co Ltd
The intrinsic value for Anterogen Co Ltd (065660) under the Base Case is hidden KRW.
Compared with the current market price of 13 980 KRW, the stock appears hidden.